Published in Clin Exp Immunol on March 01, 1967
Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin Proc (2009) 1.88
Paraproteins. Proc R Soc Med (1969) 1.31
Eosinophilic fasciitis. Case report and review of the literature. Ann Rheum Dis (1977) 1.23
A variable region subclass of heavy chains common to immunoglobulins G, A, and M and characterized by an unblocked amino-terminal residue. Proc Natl Acad Sci U S A (1970) 1.19
Comparison of different antinucleic acid antibody spectrotypes in spontaneous, induced, and murine lupus. J Clin Invest (1981) 0.90
Papular mucinosis with IgG(K) M component. Can Med Assoc J (1976) 0.77
Generalized follicular mucinosis with myxaedema. Proc R Soc Med (1968) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry (1965) 96.68
[A micro-method of immuno-electrophoresis]. Int Arch Allergy Appl Immunol (1955) 52.23
Zone electrophoresis in starch gels: group variations in the serum proteins of normal human adults. Biochem J (1955) 35.79
The hydrolysis of rabbit y-globulin and antibodies with crystalline papain. Biochem J (1959) 31.27
Starch gel electrophoresis in a discontinous system of buffers. Nature (1957) 19.23
Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds. Arch Biochem Biophys (1960) 13.40
Reduction of gamma-globulins. Arch Biochem Biophys (1962) 13.22
H CHAIN SUBGROUPS OF MYELOMA PROTEINS AND NORMAL 7S GAMMA-GLOBULIN. J Exp Med (1964) 5.64
SUBCLASSES OF HUMAN GAMMA-2-GLOBULIN BASED ON DIFFERENCES IN THE HEAVY POLYPEPTIDE CHAINS. Science (1964) 4.33
Heterogeneity of the peptide chains of gamma-globulin. Biochem J (1964) 3.25
Dependence of the chemical nature of antibodies on the net electrical charge of antigens. Proc Natl Acad Sci U S A (1966) 2.25
The use of urea-starch-gel electrophoresis in studies of reductive cleavage of an alpha 2-macroglobulin. Biochim Biophys Acta (1960) 1.66
Studies on conditions associated with disturbed gamma globulin formation (gammopathies). Harvey Lect (1962) 1.57
The hereditary human gamma globulin (Gm) groups: interpretations and extensions. Prog Allergy (1963) 1.49
Further observations on lichen myxedematosus. Ann Intern Med (1960) 1.19
AN ABNORMAL SERUM GLOBULIN IN LICHEN MYXEDEMATOSUS. Arch Dermatol (1964) 1.17
Experience with the bio-assay of the long-acting thyroid stimulator. J Clin Endocrinol Metab (1966) 0.99
A study of a case of lichen myxedematosus (papular mucinosis). Arch Dermatol (1960) 0.79
STUDIES ON THE CHROMATOGRAPHY OF HUMAN SERUM PROTEINS ON DIETHYLAMINOETHYL(DEAE)-CELLULOSE. I. THE EFFECT OF THE CHEMICAL AND PHYSICAL NATURE OF THE EXCHANGER. J Chromatogr (1964) 0.79
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
BioJava: an open-source framework for bioinformatics. Bioinformatics (2008) 6.17
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst (2000) 5.62
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol (1996) 5.09
Primary immunodeficiencies. Report of a World Health Organization Committee. Pediatrics (1971) 3.69
Biologic activities of aggregated gamma-globulin. 8. Aggregated immunoglobulins of different classes. J Immunol (1967) 3.37
A population-based study of the usefulness of screening for neuroblastoma. Lancet (1997) 2.92
Anti-lymphocytic antibody--a review. Clin Exp Immunol (1967) 2.75
Gm Phenotypes and Genotypes in U. S. Whites and Negroes; in American Indians and Eskimos; in Africans; and in Micronesians. Am J Hum Genet (1961) 2.72
Interaction forces between red cells agglutinated by antibody. II. Measurement of hydrodynamic force of breakup. Biophys J (1986) 2.43
BCG immunotherapy of bladder cancer: 20 years on. Lancet (1999) 2.38
Human monoclonal antibody production. Current status and future prospects. J Immunol Methods (1987) 2.21
Laboratory staff qualifications and accuracy of proficiency test results. A national study. Arch Pathol Lab Med (1992) 2.07
The natural history of Peyronie's disease. J Urol (1990) 2.02
Immunological changes in patient with systemic lupus erythematosus treated with topical dinitrochlorobenzene. Lancet (1995) 1.92
Granulomatous hypersensitivity. Prog Allergy (1967) 1.90
Effect of antilymphocytic antibody and antibody fragments on human lymphocytes in vitro. Nature (1967) 1.89
Psychotic men remanded in custody to Brixton Prison. Br J Psychiatry (1994) 1.77
Immunochemical properties of human gamma-A isohemagglutinin. I. Comparisons with gamma-G and gamma-M-globulin antibodies. J Immunol (1965) 1.72
Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies. Br Med J (Clin Res Ed) (1983) 1.72
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. Int J Gynecol Cancer (2003) 1.70
Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol (1999) 1.70
The regressing thin malignant melanoma: a distinctive lesion with metastatic potential. Cancer (1978) 1.69
Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. J Urol (1990) 1.66
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia (2003) 1.64
Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. J Clin Oncol (1999) 1.63
A genomewide suppressor and enhancer analysis of cdc13-1 reveals varied cellular processes influencing telomere capping in Saccharomyces cerevisiae. Genetics (2008) 1.58
ADR1-mediated regulation of ADH2 requires an inverted repeat sequence. Mol Cell Biol (1986) 1.57
Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop Relat Res (1991) 1.56
Some factors influencing the ability of anti-lymphocytic antibody to suppress humoral antibody formation. Clin Exp Immunol (1967) 1.52
Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate. Can Med Assoc J (1983) 1.52
Association of HTLV-III antibodies and cellular immune status of hemophiliacs. N Engl J Med (1984) 1.51
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol (2002) 1.50
The preparation and properties of anti-lymphocytic sera. Prog Surg (1969) 1.48
[Surgical treatment of the single non traumatic perforation of small bowel: excision-suture or resection-anastomosis]. Ann Chir (2005) 1.45
Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Clin Oncol (1993) 1.45
Prognostic features of Ewing sarcoma on plain radiograph and computed tomography scan after initial treatment. A Pediatric Oncology Group study (8346) Cancer (1993) 1.44
Melatonin administration can entrain the free-running circadian system of blind subjects. J Endocrinol (2000) 1.43
Structure-property correlations in a combinatorial library of degradable biomaterials. J Biomed Mater Res (1998) 1.42
Epidermal keratinization: localization of isotopically labeled amino acids. J Invest Dermatol (1966) 1.42
Continuous thoracic epidural analgesia versus combined spinal/thoracic epidural analgesia on pain, pulmonary function and the metabolic response following colonic resection. Acta Anaesthesiol Scand (1996) 1.42
Purification and characterization of major extracellular proteinases from Trichophyton rubrum. Biochem J (1985) 1.41
Effect of antilymphocytic antibody and antibody fragments on skin-homograft survival and the blood-lymphocyte count in rats. Lancet (1967) 1.41
Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene. J Am Acad Dermatol (1995) 1.40
Effect of anti-rat lymphocyte antibody on humoral antibody formation. Nature (1967) 1.40
Discussion paper: cross-reactivity of primate immunoglobulins. Ann N Y Acad Sci (1969) 1.38
Fluoroquinolone antibiotics: tied to tendon ruptures. Nursing (1996) 1.38
Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. J Urol (1992) 1.38
Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol (1993) 1.36
Invasion of selectively permeable sea urchin embryo basement membranes by metastatic tumor cells, but not by their normal counterparts. Cancer Res (1995) 1.35
Defect in DNA synthesis in skin of patients with xeroderma pigmentosum demonstrated in vivo. Science (1970) 1.33
In vitro studies on granulomatous hypersensitivity to beryllium. J Invest Dermatol (1970) 1.33
Cell renewal in human epidermis. Arch Dermatol (1965) 1.33
Sulfur-containing proteins and epidermal keratinization. J Cell Biol (1969) 1.32
Ultraviolet light, DNA repair and skin carcinogenesis in man. Fed Proc (1972) 1.32
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1996) 1.32
The origin of epithelioid cells in experimental granulomas of man. Lab Invest (1968) 1.31
beta 2-microglogulin levels in cancerous and other disease states. Clin Chim Acta (1976) 1.29
Characterization of antilymphocytic antibody. Nature (1967) 1.27
Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma. J Clin Oncol (1998) 1.27
Characterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography. Br J Surg (1993) 1.26
Ultrastructural observations on experimentally induced foreign-body and organized epithelioid-cell granulomas in man. Am J Pathol (1968) 1.26
The distribution and possible significance of cells identified in human lymphoid tissue by the monoclonal antibody HNK-1. Clin Exp Immunol (1983) 1.25
Ultrastructural autoradiographic studies of keratohyalin granule formation. J Invest Dermatol (1967) 1.25
Multiple organ damage caused by a new toxin azaspiracid, isolated from mussels produced in Ireland. Toxicon (2000) 1.23
New allele at cholinesterase locus 1. J Med Genet (1976) 1.20
A population-based study of neuroblastoma incidence, survival, and mortality in North America. J Clin Oncol (1992) 1.20
Early effects of ultraviolet light on DNA synthesis in human skin in vivo. Arch Dermatol (1969) 1.18
Normal and pathological serum levels of alpha2-macroglobulins in men and mice. J Clin Pathol (1975) 1.18
Biological properties of human melanoma cells in culture. In Vitro (1979) 1.18
Evolution of a recombinant (gucoamylase-producing) strain of Fusarium venenatum A3/5 in chemostat culture. Biotechnol Bioeng (2001) 1.17
Prolongation of canine renal allograft survival with antilymphocytic serum. Transplantation (1968) 1.16
UVL induced stimulation of DNA synthesis in hairless mouse epidermis. J Invest Dermatol (1968) 1.15
The effect of anti-lymphocytic antibody on the humoral immune response in different strains of mice. I. The response to bovine serum albumin. Immunology (1972) 1.15
Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guérin (BCG) immunotherapy. Clin Exp Immunol (1995) 1.14
Interaction between prognostic factors and treatment. Control Clin Trials (1983) 1.14
Topically applied antifungal agents. Percutaneous penetration and prophylactic activity against trichophyton mentagrophytes infection. Arch Dermatol (1977) 1.14
Flexible eating and flexible insulin dosing in patients with diabetes: Results of an intensive self-management course. Diabetes Res Clin Pract (2008) 1.13
Formation of multinucleate giant cells in organized epitheloid cell granulomas. Am J Pathol (1974) 1.13
Quantitative studies with antilymphocytic antibody. Nature (1967) 1.13
Carcinoembryonic antigen (CEA): molecular biology and clinical significance. Biochim Biophys Acta (1975) 1.13
Cutaneous changes in the porphyrias. A microscopic study. Arch Dermatol (1973) 1.12
Griseofulvin levels in stratum corneum. Study after oral administration in man. Arch Dermatol (1972) 1.12
The antecedents of violence and aggression within psychiatric in-patient settings. Acta Psychiatr Scand (2012) 1.10
Two tris urea mercaptoethanol extractable polypeptides found uniquely in scales of patients with psoriasis. J Invest Dermatol (1978) 1.09
Nuclear changes during keratinization of normal human epidermis. J Ultrastruct Res (1971) 1.09
Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol (1992) 1.09
Binding of C-reactive protein to human lymphocytes. II. Interaction with a subset of cells bearing the Fc receptor. J Immunol (1981) 1.08
Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study. J Urol (1993) 1.08
Role of adherent cells in immune responses to phytohemagglutinin and concanavalin A. Eur J Immunol (1978) 1.07
Detection and characterization of epidermal proteinases by polyacrylamide gel electrophoresis. Comp Biochem Physiol B (1984) 1.06
Editorial: How clinically useful is T and B cell quantitation? Ann Intern Med (1974) 1.06
Preliminary observations on the effect of heterologous anti-lymphocytic globulin on autologous immune complex nephritis in rats. Clin Exp Immunol (1969) 1.06
Mechanisms of action of intravesical bacille Calmette-Guérin: local immune mechanisms. Clin Infect Dis (2000) 1.06
Distribution of fatty and fibrous plaques in young human coronary arteries. Atherosclerosis (1982) 1.05
Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids. Clin Exp Allergy (2008) 1.05